BlueLinx (BXC) Q3 2024 earnings summary

Executive summary

• Net sales for Q3 2024 were $747 million (down 7.7%-8% year-over-year) due to price deflation in both specialty and structural products, partially offset by volume gains.

• Gross profit was $126 million (16.8% margin), with net income of $16 million ($1.87 per share); adjusted net income was $17 million ($1.95 per share).

• Adjusted EBITDA was $37 million (4.9% margin), including a $3.5 million duty-related benefit; free cash flow reached $54 million.

• Specialty products accounted for 70% of sales and 80% of gross profit, with strong volume growth in key categories offsetting price declines.

• Share repurchases totaled $15 million in Q3, with $61 million remaining authorized.

Financial highlights

• Gross margin was 16.8% (down 40 bps year-over-year); specialty product gross margin was 19.4% (18.7% excluding duty benefit), and structural product gross margin was 11.0%.

• Adjusted EBITDA margin was 4.9% (4.4% excluding duty benefit); net income margin was 2.1%-2.2%.

• SG&A expenses rose to $92 million, mainly due to higher technology costs.

• Operating cash flow was $62 million; free cash flow was $54 million.

• Net leverage ratio was (1.2x); net debt was ($176 million).

Outlook and guidance

• Q4 specialty product gross margin expected in the 18%-19% range; structural product gross margin in the 9%-10% range.

• Sequential daily sales volume in Q4 expected to be slightly lower than Q3 but higher year-over-year.

• Management expects pricing improvement in 2025, likely in the back half, as the housing market recovers.

• Capital investments for 2024 anticipated to be slightly below $40 million, focused on facilities, fleet, and technology.

• Annual effective income tax rate for 2024 expected to be approximately 26%.